Extended stability studies of PTH-IA
Active Awarded Last action
- Contract number
- 75N95025F00001
- Awardee
-
Bachem Americas Inc. UEI ULM6JMNK5L83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,400
Award facts
- Contract value 100% obligated
- $26,400.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Torrance, CA 90505, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support NCATS' drug development and manufacturing programs. No set-aside designation was used for this award, and Bachem appears to be the prime contractor without any major subcontractors mentioned.
Quick answers
Who was awarded contract 75N95025F00001?
75N95025F00001 was awarded to Bachem Americas Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 13, 2025.
How much is contract 75N95025F00001 worth?
The government has obligated $26,400 on 75N95025F00001.
Which agency awarded contract 75N95025F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95025F00001 an order under another contract?
Yes. 75N95025F00001 is a delivery order under 75N95024D00009, an indefinite delivery contract, on NCATS Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances.
Was contract 75N95025F00001 competed?
The extent of competition for 75N95025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award